Skip to content

Bausch Health Companies BHC Intangible Purchases

Intangible Purchases at other companies

Organon logo
OrganonOGN
$0-100%
HRO
HarrowHROW
$9K-78.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$5.25M-69.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0-100%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$10M

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's intangible purchases?
Bausch Health Companies (BHC) reported intangible purchases of $38M in Q1 2026.
How has Bausch Health Companies's intangible purchases changed year-over-year?
Bausch Health Companies's intangible purchases increased by 322.2% year-over-year, from $9M to $38M.
What is the long-term trend for Bausch Health Companies's intangible purchases?
Over 3 years (2021 to 2024), Bausch Health Companies's intangible purchases has grown at a -40.2% compound annual growth rate (CAGR), from $14M to $3M.
What does intangible purchases mean?
Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.